Elliott Dasenbrook, MD

Contact Information




Elliott Dasenbrook, MD

Associate Professor

  • Division: Pulmonology, Allergy and Immunology


Dr. Dasenbrook received his undergraduate degree from Loyola University Chicago in 1997. He earned his medical degree in 2001 from Loyola University of Chicago, Stritch School of Medicine. He completed a residency in internal medicine and served as chief resident at Loyola University Medical Center in 2004 and 2005. Dr. Dasenbrook earned his masters in health services in 2008 and completed a fellowship in Pulmonary and Critical Care Medicine from John Hopkins University School of Medicine in 2009. 

Research Interests

My primary research interests are in identifying and reversing modifiable risk factors associated with decreased survival, designing clinical trials to test novel interventions in patients with cystic fibrosis (CF), and conducting Phase I-IV clinical trials. I am the PI for the Adult CF Center Therapeutic Development Network Site and our team conducts investigator-initiated, NIH, and pharmaceutical funded Phase I-IV studies in order to test the safety and efficacy of new CF therapeutics. Our team has had over 40 active patient protocols in the last two years. I am the Associate Chair of the US CF Foundation Patient Registry Committee and our research group conducts complex cohort studies and comparative effectiveness research to further understand the pathophysiology, diagnosis, prognosis and treatment of CF. Funded investigator-initiated studies where I am the PI include studies testing a novel formulation of inhaled vancomycin to eradicate chronic MRSA, evaluating a novel MRI technique for the detection of early-stage CF lung disease, and performing a Phase I safety study of mesenchymal stem cells as a therapeutic intervention for adults with cystic fibrosis. The ultimate goal of all these studies is to improve survival in patients with CF.